The Shanghai epidemic prevention and control work press conference notified that on January 21, Shanghai reported 3 confirmed cases of local new coronary pneumonia.

Three cases have been traced in close contact with 71 people in Shanghai, after 24 hours to conduct sampling review.

The Zhaotong residential area of ​​Huangpu District (the area south of Fuzhou Road) is classified as a medium-risk area, and the risk level of other areas in Shanghai remains unchanged.

Case details:

　　Case 1, Li Moumou, male, 56 years old.

At about 15:00 on January 20th, the Fudan University Affiliated Cancer Hospital carried out routine nucleic acid testing of the new coronavirus for outsourced logistics personnel of the hospital, and found that a sample of 10 people was tested suspiciously.

In the early morning of January 21, the sample of Case 1 was reviewed by the Municipal Center for Disease Control and Prevention, and the nucleic acid test result was positive.

　　Case 2, Zhou Moumou, male, 53 years old, a neighbor in the same community as Case 1.

Renji Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, conducted a routine nucleic acid test for the new coronavirus on the relevant personnel of the hospital on the afternoon of January 20. It was found that a sample of 10 people was tested suspiciously. In the early morning of January 21, case 2 The sample was reviewed by the Municipal Center for Disease Control and the nucleic acid test result was positive.

　　Case 3, Tian Moumou, female, 48 years old, is a friend of Case 1.

In the early morning of January 21, the Municipal Center for Disease Control found that Case 3 had a positive nucleic acid test for the new coronavirus during the investigation of the close contacts of Case 1.

　　After consultation with city-level experts, combined with clinical, imaging findings and laboratory nucleic acid test results, all three persons were diagnosed with confirmed cases of new coronary pneumonia and were transferred to the Shanghai Public Health Clinical Center for isolation and treatment.

Editor in charge: [Lu Yan]